Has Jonathan Steinberg received payments from drug or device companies?

Yes. Drug and device makers reported $4,722 in general payments to Jonathan Steinberg across 101 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jonathan Steinberg did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jonathan Steinberg come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jonathan Steinberg

Gastroenterology · West Palm Beach, FLNPI 1770087686

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.4% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 32.7% of the total. 2025 is the largest year on record at $1,789, 7.6 times the $236 reported in 2022.

$4,722in general payments, 2019–2025

Across 101 payments — averaging $46.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Balt USA, LLC$904
Johnson & Johnson$556
Boston Scientific$250
Mallinckrodt Hospital Products Inc.$183
Phathom Pharmaceuticals, Inc.$170
plus $1K from 15 others

What the payments were for

Food & beverage$4,69399%
Education$291%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	37	$1,545
Balt USA, LLC	5	$904
Johnson & Johnson	16	$556
Boston Scientific	3	$250
Mallinckrodt Hospital Products Inc.	6	$183
Phathom Pharmaceuticals, Inc.	3	$170
Steris Corporation	1	$145
Takeda Pharmaceuticals U.S.A., Inc.	7	$144
Ardelyx, Inc.	5	$130
Novo Nordisk	1	$125
Regeneron Healthcare Solutions, Inc.	1	$120
Sanofi	2	$99
Lilly USA, LLC	3	$94
Gilead	2	$52
Alnylam Pharmaceuticals Inc.	2	$43
Intercept Pharmaceuticals, Inc.	2	$40
Madrigal Pharmaceuticals	1	$33
Celltrion USA Inc.	1	$29
Ferring Pharmaceuticals Inc.	1	$24
Sumitomo Pharma America, Inc.	1	$23
Merck	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,722 in reported general payments places this provider in the 60th percentile of 1,388 gastroenterology providers in Florida.

See all gastroenterology providers in Florida →

Other gastroenterology in West Palm Beach

Sonja OlsenWest Palm Beach$220K
Samuel GidayOrlando$2M
Lukasz KwapiszMiami$1.2M
Jennifer Seminerio-DiehlOrlando$1.1M
Udayakumar NavaneethanSaint Petersburg$1.1M
Ronen AraiCoral Springs$1.1M
Charles SninskyGainesville$983K
Peter DraganovGainesville$832K
Arin NewmanMiami Beach$716K
Joanna LopezMiami$670K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →